Raymond James & Associates Ark Genomic Revolution ETF (De Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Raymond James & Associates holds 60,535 shares of ARKG stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,535
Previous 82,411
26.55%
Holding current value
$1.44 Million
Previous $1.94 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ARKG
# of Institutions
277Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$81.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$78.3 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$60.9 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$56.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$28.7 Million0.0% of portfolio